fatnews.com Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Belviq (lorcaserin) side effects: Hypoglycemia in 29% of patients vs 21% with placebo


    Posted by .(JavaScript must be enabled to view this email address)
    Saturday, June 22, 2013 2:59 pm Email this article

    Hypoglycemia was reported in 29.3% of patients given the weight loss drug, Belviq (lorcaserin), versus 21% of patients given a placebo according to studies performed leading up to the FDA approval of the drug.

    Reference

    Belviq (lorcaserin hydrochloride) Prescribing Information. Revision 08/2012.
    http://www.belviq.com/pdf/Belviq_Prescribing_information.pdf

     

    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.